Antibacterial activities of 5-nitro-2-furyl and 5-nitro-2-imidazolyl derivatives of 1,3,4-thiadiazole

Keywords

Nitrofuran
Nitroimidazole
Minimum Inhibitory Concentration
Ciprofloxacin

How to Cite

Doostishoar, F. (2019). Antibacterial activities of 5-nitro-2-furyl and 5-nitro-2-imidazolyl derivatives of 1,3,4-thiadiazole. Internal Medicine and Medical Investigation Journal, 4(2). https://doi.org/10.24200/imminv.v4i2.213

Abstract

Background and Aims: Nitrofurans and nitroimidazoles are broad spectrum antimicrobial agents which affect the microbial DNA. The aims of the present study were to evaluate the new derivatives of these two groups against certain Gram positive and Gram negative bacterial strains.

Materials and Methods: Seven new derivatives of nitrofuran and nitroimidazoles were synthesized and 6.4 mg of each derivative were dissolved in dimethyl sulfioxide. Then, 8 serial dilutions of agents were prepared as 0.5, 1, 2, 4, 8, 16, 32 and 64 μg/ml using Muller-Hinton broth and minimum inhibitory concentration (MIC) for each derivative was measured and compared to ciprofloxacin as a standard.

Results: All derivatives had no antibacterial effects against Gram negative bacteria (MIC > 64 μg/ml) and just 2-(5-nitro-2-furyl)-5-(n-pentylsulfunyl)-1,3,4-thiadiazole had mild antibacterial effects against Klebsiella pneumonia (MIC of 16-32 μg/ml). The antibacterial effects of derivatives against Gram positive bacteria also showed variations from completely inhibited the growth of Staphylococcus epidermidis and Bacillus subtilis (MIC < 0.5 μg/ml) by 2-(5-nitro-2-furyl)-5-(n-buthylthio)-1,3,4-thiadiazole to no inhibition of S. epidermidis and streptococcus pyogenes.

Conclusions: These compounds have weak antibacterial effects and just two of them showed antibacterial effects quite similar to that of positive control.

 

Keywords: Nitrofuran, Nitroimidazole, minimum inhibitory concentration, ciprofloxacin.

https://doi.org/10.24200/imminv.v4i2.213

References

1. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics. 2015;40(4):277.
2. Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. Jama. 2016;316(11):1193-204.
3. Mardani M, Afra SM, Tanideh N, Andisheh Tadbir A, Modarresi F, Koohi‐Hosseinabadi O, et al. Hydroalcoholic extract of Carum carvi L. in oral mucositis: a clinical trial in male golden hamsters. Oral diseases. 2016;22(1):39-45.
4. Moshafi MH, Doostishoar F, Jahanian A, Abaszadeh M. Antimicrobial effects of new designed 2-amino-tetrahydro-4H-chromene-3-carbonitrile derivatives against some pathogenic microbial strains. Comparative Clinical Pathology. 2016;25(6):1197-200.
5. Rusen E, Diacon A, Mocanu A, Rizea F, Bucur B, Bucur MP, et al. Synthesis and retention properties of molecularly imprinted polymers for antibiotics containing a 5-nitrofuran ring. RSC Advances. 2017;7(80):50844-52.
6. Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs. 2001;61(3):353-64.
7. Muller M, editor Reductive activation of nitroimidazoles in anaerobic microorganisms. Bioreduction in the Activation of Drugs: Proceedings of the Second Biochemical Pharmacology Symposium, Oxford, UK, 25-26 July 1985; 2013: Elsevier.
8. Edwards DI, editor Reduction of nitroimidazoles in vitro and DNA damage. Bioreduction in the Activation of Drugs: Proceedings of the Second Biochemical Pharmacology Symposium, Oxford, UK, 25-26 July 1985; 2013: Elsevier.
9. Jain AK, Sharma S, Vaidya A, Ravichandran V, Agrawal RK. 1, 3, 4‐Thiadiazole and its Derivatives: A Review on Recent Progress in Biological Activities. Chemical biology & drug design. 2013;81(5):557-76.
10. Ryan K, Ray C. Sherris Medical Microbiology. London: McGraw Hill 2000; 2000.
11. Koohi-Hosseinabadi O, Moini M, Safarpoor A, Derakhshanfar A, Sepehrimanesh M. Effects of dietary Thymus vulgaris extract alone or with atorvastatin on the liver, kidney, heart, and brain histopathological features in diabetic and hyperlipidemic male rats. Comparative Clinical Pathology. 2015;24(6):1311-5.
12. Foroumadi A, Mirzaei M, Shafiee A. Antituberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1, 3, 4-thiadiazole derivatives. Farmaco (Societa chimica italiana: 1989). 2001;56(8):621.
13. Foroumadi A, Asadipour A, Mirzaei M, Karimi J, Emami S. Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1, 3, 4-thiadiazole derivatives. Il Farmaco. 2002;9(57):765-9.
14. Foroumadi A, Soltani F, Moshefi M, Ashraf-Askari R. Synthesis and in vitro antibacterial activity of some n-(5-aryl-1, 3, 4-thiadiazole-2-yl) piperazinyl quinolone derivatives. Il Farmaco. 2003;58(10):1023-8.
15. Alireza F, Mohsen D, Abbas S. Synthesis and in vitro antifungal activity of 2-aryl-5-phenylsulfonyl-1, 3, 4-thiadiazole derivatives. Arzneimittelforschung. 1999;49(12):1035-8.
16. Foroumadi A, Kargar Z, Sakhteman A, Sharifzadeh Z, Feyzmohammadi R, Kazemi M, et al. Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1, 3, 4-thiadiazol-2-ylthio] propionates. Bioorganic & medicinal chemistry letters. 2006;16(5):1164-7.
17. Foroumadi A, Soltani F, Jabini R, Moshafi MH, Rasnani FM. Antituberculosis agents x. synthesis and evaluation ofIn Vitro antituberculosis activity of 2-(5-nitro-2-furyl)-and 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-1, 3, 4-thiadiazole derivatives. Archives of pharmacal research. 2004;27(5):502-6.
18. Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Medicinal research reviews. 2003;23(2):146-89.
19. Abdel-Wahab BF, Abdel-Aziz HA, Ahmed EM. Synthesis and antimicrobial evaluation of some 1, 3-thiazole, 1, 3, 4-thiadiazole, 1, 2, 4-triazole, and 1, 2, 4-triazolo [3, 4-b][1, 3, 4]-thiadiazine derivatives including a 5-(benzofuran-2-yl)-1-phenylpyrazole moiety. Monatshefte für Chemie-Chemical Monthly. 2009;140(6):601-5.
20. Padmavathi V, Reddy GD, Reddy SN, Mahesh K. Synthesis and biological activity of 2-(bis ((1, 3, 4-oxadiazolyl/1, 3, 4-thiadiazolyl) methylthio) methylene) malononitriles. European journal of medicinal chemistry. 2011;46(4):1367-73.
21. Kadi AA, Al-Abdullah ES, Shehata IA, Habib EE, Ibrahim TM, El-Emam AA. Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1, 3, 4-thiadiazole derivatives. European journal of medicinal chemistry. 2010;45(11):5006-11.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.